New Shockwave Coronary IVL Publications Confirm Safety And Efficacy Across Multiple Calcium Morphologies
Shockwave Medical, Inc. (NASDAQ:SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, announced today that two new publications reported